The Truth about Teams
When it comes to team performance and adherence to “best practices,” what works…
Running the Biopharma Marathon
When I moved to Boston over thirty years ago, I had never even heard of the…
Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to…
“Rare Disease” Is More Than Just a Day
You might think it odd for me to begin this month’s e-conversation with a quote…
Power to the People
Each month, as I ponder possible topics for this e-conversation, I find myself struggling with the same challenge: So many things to talk about; so…
Getting More from Your Biopharma Consulting Engagement
It is always risky to read one HBR article and then assume you can apply it to every other work scenario in front of you. But here we go anyway. In…
Nature vs. Nurture
We have been publishing these "e-conversations" for just six months now. But I am happy — no, thrilled — to see that it has already become exactly…
Where Has All the Brand Planning Strategy Gone?
Back in the Mesozoic Era, when I was coming up the marketing line (also known as the 90s), we used something called "The Mapping Approach to…
What More Can We Do To Help?
Our last newsletter concluded with the following question: "If you could have an unlimited supply of anything, what would it be?" It was a question…
Important Questions That Move Us Forward
I had two reasons for attending TEDMED in Palm Springs earlier this month. First, I wanted to be inspired! Second, I wanted to learn more about…
Reactive Leadership in Biopharma: Breaking the Whac-A-Mole Cycle
Today we examine a pervasive challenge in our industry: time and resources wasted as middle and senior leaders respond to a seemingly endless, daily…
Your Future Story … How Good Is It?
Summer, sadly, is over. And while there are noticeable shifts with each change of season, I find the transition into autumn can often be bittersweet.